Philippe Bedard

Philippe Bedard, MD, FRCPC

Follow Dr. Bedard:

Dr. Bedard received his medical degree from the University of Toronto where he was awarded the Cody Academic Silver Medal. He completed his Internal Medicine and Medical Oncology specialty training at the University of Toronto. He received additional fellowship training in clinical and translational breast cancer research at the Breast International Group (BIG).
In recognition of his research excellence, Dr. Bedard received the 2012 Career Development Award from the the Conquer Cancer Foundation of the American Society of Clinical Oncology.

Dr. Bedard has a clinical practice and a research program. His clinical practice includes the treatment of patients with breast and testicular cancers. His research program involves early phase clinical trials with novel cancer drug treatments. These emerging treatments include immunotherapy and the personalization of cancer treatment based upon the results of testing for DNA mutations within tumor cells.
As a member of the Steering Committee for the AACR-GENIE project, Dr. Bedard is contributing to this international data-sharing initiative, which links cancer genomic data with clinical outcomes from tens of thousands of cancer patients treated at leading international institutions.

Support Care Cancer. 2017 Feb 02;:
Lewin J, Ma JM, Mitchell L, Tam S, Puri N, Stephens D, Srikanthan A, Bedard P, Razak A, Crump M, Warr D, Giuliani M, Gupta A
J Clin Oncol. 2016 Jan 20;34(3_suppl):199
D'Agostino NM, Pond GR, Aubin S, Matthew A, Gupta AA, Kavan P, Crump M, Bedard PL, Schuh AC, Hodgson DC, Wahl K, Simpson R, Vuong T, Muanza T, Batist G, Bernstein LJ
Gynecol Oncol. 2017 Jan 03;:
Spreafico A, Oza AM, Clarke BA, Mackay HJ, Shaw P, Butler M, Dhani NC, Lheureux S, Wilson MK, Welch S, Zhang T, Yu C, Stockley T, Siu LL, Kamel-Reid S, Bedard PL
Genome Med. 2016 Oct 25;8(1):109
Stockley TL, Oza AM, Berman HK, Leighl NB, Knox JJ, Shepherd FA, Chen EX, Krzyzanowska MK, Dhani N, Joshua AM, Tsao MS, Serra S, Clarke B, Roehrl MH, Zhang T, Sukhai MA, Califaretti N, Trinkaus M, Shaw P, van der Kwast T, Wang L, Virtanen C, Kim RH,...
Can Urol Assoc J. 2016 May-Jun;10(5-6):204-209
Nayan M, Jewett MA, Anson-Cartwright L, Bedard PL, Moore M, Chung P, Warde P, Sweet J, O'Malley M, Hamilton RJ
Am J Cardiol. 2016 Aug 23;
Thomas GR, McDonald MA, Day J, Ross HJ, Delgado DH, Billia F, Butany JW, Rao V, Amir E, Bedard PL, Thavendiranathan P
Cold Spring Harb Mol Case Stud. 2016 Sep;2(5):a001016
Aung KL, Stockley TL, Serra S, Kamel-Reid S, Bedard PL, Siu LL
Nat Genet. 2016 Aug 29;
Bailey SD, Desai K, Kron KJ, Mazrooei P, Sinnott-Armstrong NA, Treloar AE, Dowar M, Thu KL, Cescon DW, Silvester J, Yang SY, Wu X, Pezo RC, Haibe-Kains B, Mak TW, Bedard PL, Pugh TJ, Sallari RC, Lupien M
Eur Urol. 2016 Aug 12;
Nayan M, Jewett MA, Hosni A, Anson-Cartwright L, Bedard PL, Moore M, Hansen AR, Chung P, Warde P, Sweet J, O'Malley M, Atenafu EG, Hamilton RJ
Invest New Drugs. 2016 Jul 23;
Grilley-Olson JE, Bedard PL, Fasolo A, Cornfeld M, Cartee L, Razak AR, Stayner LA, Wu Y, Greenwood R, Singh R, Lee CB, Bendell J, Burris HA, Del Conte G, Sessa C, Infante JR



Associate Professor, Faculty of Medicine, University of Toronto
Member, Steering Committee, American Association for Cancer Research (AACR) Genomics, Evidence, Neoplasia, Information, Exchange (GENIE) Project
Staff Medical Oncologist, Division of Medical Oncology, Princess Margaret Cancer Centre
Fellowship Director, Bras Drug Development Program, Princess Margaret Cancer Centre
Clinical Director, Cancer Genomics Program, Princess Margaret Cancer Centre